Literature DB >> 19375125

Metabolism of histamine in tissues of primary ductal breast cancer.

Jarosław von Mach-Szczypiński1, Stanisław Stanosz, Krzysztof Sieja, Małgorzata Stanosz.   

Abstract

Histamine performs an important role in the pathologic and physiologic aspects of the breast gland. Among monoamines, histamine demonstrates the greatest proliferative activity in breast cancer. The aim of the study was to evaluate histamine concentration in plasma and tissues of breast cancer dependent on the activity of histamine metabolism enzymes in neoplasmatic tissues of the breast gland. Ninety-five women aged 38 to 70 years were divided into 2 groups. The control group (group I) consisted of 30 healthy women. Group II consisted of 65 women with primary ductal breast cancer. The concentration of histamine in plasma was assessed by immunoenzymatic method. The concentration of histamine in cancerous tissues of the breast and the metabolism of histamine enzymes, specially histidine decarboxylase, decarboxylase of aromatic L-amino acids, N-histamine methyltransferase, monoamine oxydase B, and diamine oxydase, were determined using isotope technique. In the course of 24 hours, excretion of N-methylimidazoleacetic acid was evaluated by the methods of chromatography. The statistical analysis was made based on Statistica Pl Ed (StatSoft, Cracow, Poland, 1998). A significant increase in the concentration of histamine in plasma (P < .01) and tissues of ductal breast cancers (P < .001), and in the activity of histidine decarboxylase (P < .01), aromatic L-amino acids (P < .05), and histamine methyltransferase (P < .05) was found. Activity of monoamine oxidase B (P < .01) and diamine oxidase (P < 0.01) and excretion of N-methylimidazoleacetic acid were significantly decreased compared with the control group (P < 0.001). The conclusions are as follows: (1) Concentration of histamine in the plasma of women is dependent on the concentration of histamine in the tissues of ductal breast cancers. (2) The significant increase of histamine in cancerous tissues of ductal breast cancer could suggest the participation of this monoamine in the development of breast cancer. (3) The increase of histamine concentrations in ductal breast cancer tissues can be connected with the disturbances of the balance between synthesis and enzymatic inactivation of this monoamine. (4) The concentration of histamine in the plasma of women with ductal breast cancers is dependent on the number of involved lymph nodes and the grade of histologic malignancy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375125     DOI: 10.1016/j.metabol.2009.02.011

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

Review 1.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

Review 2.  Histamine receptors and cancer pharmacology.

Authors:  Vanina A Medina; Elena S Rivera
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

3.  The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1.

Authors:  Hongzhong Li; Yi Xiao; Qin Li; Jun Yao; Xiangliang Yuan; Yuan Zhang; Xuedong Yin; Yohei Saito; Huihui Fan; Ping Li; Wen-Ling Kuo; Angela Halpin; Don L Gibbons; Hideo Yagita; Zhongming Zhao; Da Pang; Guosheng Ren; Cassian Yee; J Jack Lee; Dihua Yu
Journal:  Cancer Cell       Date:  2021-11-24       Impact factor: 31.743

4.  Integrated Network Pharmacology Approach for Drug Combination Discovery: A Multi-Cancer Case Study.

Authors:  Antonio Federico; Michele Fratello; Giovanni Scala; Lena Möbus; Alisa Pavel; Giusy Del Giudice; Michele Ceccarelli; Valerio Costa; Alfredo Ciccodicola; Vittorio Fortino; Angela Serra; Dario Greco
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

5.  Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

6.  Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.

Authors:  Carmen Herranz; Francesca Mateo; Alexandra Baiges; Gorka Ruiz de Garibay; Alexandra Junza; Simon R Johnson; Suzanne Miller; Nadia García; Jordi Capellades; Antonio Gómez; August Vidal; Luis Palomero; Roderic Espín; Ana I Extremera; Eline Blommaert; Eva Revilla-López; Berta Saez; Susana Gómez-Ollés; Julio Ancochea; Claudia Valenzuela; Tamara Alonso; Piedad Ussetti; Rosalía Laporta; Antoni Xaubet; José A Rodríguez-Portal; Ana Montes-Worboys; Carlos Machahua; Jaume Bordas; Javier A Menendez; Josep M Cruzado; Roser Guiteras; Christophe Bontoux; Concettina La Motta; Aleix Noguera-Castells; Mario Mancino; Enrique Lastra; Raúl Rigo-Bonnin; Jose C Perales; Francesc Viñals; Alvaro Lahiguera; Xiaohu Zhang; Daniel Cuadras; Coline H M van Moorsel; Joanne J van der Vis; Marian J R Quanjel; Harilaos Filippakis; Razq Hakem; Chiara Gorrini; Marc Ferrer; Aslihan Ugun-Klusek; Ellen Billett; Elżbieta Radzikowska; Álvaro Casanova; María Molina-Molina; Antonio Roman; Oscar Yanes; Miquel A Pujana
Journal:  EMBO Mol Med       Date:  2021-08-11       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.